These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 35279145)
1. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1. Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890 [TBL] [Abstract][Full Text] [Related]
3. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway. Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810 [TBL] [Abstract][Full Text] [Related]
4. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling. Lu Y; Zhao X; Liu Q; Li C; Graves-Deal R; Cao Z; Singh B; Franklin JL; Wang J; Hu H; Wei T; Yang M; Yeatman TJ; Lee E; Saito-Diaz K; Hinger S; Patton JG; Chung CH; Emmrich S; Klusmann JH; Fan D; Coffey RJ Nat Med; 2017 Nov; 23(11):1331-1341. PubMed ID: 29035371 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274 [TBL] [Abstract][Full Text] [Related]
6. m Wu Y; Yang X; Chen Z; Tian L; Jiang G; Chen F; Li J; An P; Lu L; Luo N; Du J; Shan H; Liu H; Wang H Mol Cancer; 2019 Apr; 18(1):87. PubMed ID: 30979372 [TBL] [Abstract][Full Text] [Related]
7. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling. Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986 [TBL] [Abstract][Full Text] [Related]
8. LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway. Li J; He M; Xu W; Huang S J Exp Clin Cancer Res; 2019 Apr; 38(1):161. PubMed ID: 30987669 [TBL] [Abstract][Full Text] [Related]
9. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway. Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010 [TBL] [Abstract][Full Text] [Related]
10. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer. Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874 [TBL] [Abstract][Full Text] [Related]
11. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer. Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371 [TBL] [Abstract][Full Text] [Related]
12. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway. Tao Y; Han T; Zhang T; Ma C; Sun C Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582 [TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer. Wang J; Zhang J; Liu H; Meng L; Gao X; Zhao Y; Wang C; Gao X; Fan A; Cao T; Fan D; Zhao X; Lu Y Cancer Commun (Lond); 2024 Apr; 44(4):469-490. PubMed ID: 38512764 [TBL] [Abstract][Full Text] [Related]
14. LINC00982-encoded protein PRDM16-DT regulates Hu HF; Han L; Fu JY; He X; Tan JF; Chen QP; Han JR; He QY Theranostics; 2024; 14(8):3317-3338. PubMed ID: 38855188 [TBL] [Abstract][Full Text] [Related]
15. MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3. Peng C; Li X; Yao Y; Nie Y; Fan L; Zhu C Cancer Biol Ther; 2024 Dec; 25(1):2373497. PubMed ID: 38967961 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway. Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015 [TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway. Zhang X; Yao J; Shi H; Gao B; Zhou H; Zhang Y; Zhao D; Gao S; Wang C; Zhang L Cell Death Dis; 2021 Aug; 12(9):802. PubMed ID: 34420031 [TBL] [Abstract][Full Text] [Related]
18. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer. Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372 [TBL] [Abstract][Full Text] [Related]
19. SNHG16 upregulation-induced positive feedback loop with YAP1/TEAD1 complex in Colorectal Cancer cell lines facilitates liver metastasis of colorectal cancer by modulating CTCs epithelial-mesenchymal transition. Xiang Z; Huang G; Wu H; He Q; Yang C; Dou R; Liu Q; Song J; Fang Y; Wang S; Xiong B Int J Biol Sci; 2022; 18(14):5291-5308. PubMed ID: 36147462 [TBL] [Abstract][Full Text] [Related]
20. Constitutive β-Catenin Overexpression Represses Lncrna MIR100HG Transcription via HDAC6-Mediated Histone Modification in Colorectal Cancer. Peng J; Ma Y; Zhao X; Yang X; Wang H Mol Cancer Res; 2022 Jun; 20(6):949-959. PubMed ID: 35247921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]